Primary lymphoma of bone: An institutional experience

Leukemia and Lymphoma

Volumn 49, Issue 11, 2008, Pages 2125-2132

  Catlett, Joseph P ^a   Williams, Stephen A ^b   O'Connor, Shannon C ^a   Krishnan, Jayashree ^a   Malkovska, Vera ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b Roseburg Medical Oncology   (United States)

Author keywords

Bone; Chemotherapeutic approaches; Chemotherapy; Lymphoma; Neoplasia; Radiation; Rituximab

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; B CELL LYMPHOMA; BONE CANCER; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; IMMUNOBLASTIC LYMPHOMA; LARGE CELL LYMPHOMA; LYMPHOMA; MALE; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; T CELL LYMPHOMA;

AGE FACTORS; BONE NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 57049105654     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802404030     Document Type: Article

References (28)

1. Shannon, J. A., Bell, D. R., Levi, J. A., Wheeler, H. R. and Boyle, F. M. (1994) Bone presentation of non-Hodgkin's lymphoma: Experience at the Royal North Shore Hospital, Sydney; highlighting primary bone lymphoma. Aust NZ J Med, 24, pp. 701-704.
2. Dubey, P., Chul, S. H., Besa, P. C., Fuller, L., Cabanillas, F. Murray, J. et al. (1997) Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys, 37, pp. 1087-1093.
3. Oberling, C. (1928) Les réticulosarcomes et les reticuloendothéliosarcomes de la moelles osseuse (sarcomes d'Ewing). Bull Assoc Fr Etude Cancer (Paris), 17, pp. 259-296.
4. Parker, F. and Jackson, H. (1939) Primary reticulum cell sarcoma of bone. Surg Gynaecol Obstet, 68, pp. 45-53.
5. Suryanarayan, K., Shuster, J. J., Donaldson, S. S., Hutchison, R. E., Murphy, S. B. and Link, M. P. (1999) Treatment of localized primary non-Hodgkin's lymphoma of bone in children: A pediatric oncology group study. J Clin Oncol, 17, pp. 456-459.
6. Ostrowski, M. L., Unni, K. K., Banks, P. M., Shives, T. C., Evans, R. G. O'Connell, M. J. et al. (1986) Malignant lymphoma of bone. Cancer, 58, pp. 2646-2655.
7. Desai, S., Jambheka, N. A., Chitralekha, S. S. and Advani, S. H. (1991) Primary lymphoma of bone: A clinicopathologic study of 25 cases reported over 10 years. J Surg Oncol, 46, pp. 265-269.
8. Jaffe, E. S., Harris, N. L., Stein, H. and Vardiman, J. W. (2001) IARC Press, Lyon
9. Fairbanks, R. K., Bonner, J. A., Inwards, C. Y., Strickler, J. G., Habermann, T. H. Unni, K. K. et al. (1993) Treatment of stage IE primary lymphoma of bone. Int J Radiat Oncol Biol Phys, 28, pp. 363-372.
10. Lewis, V. O., Primus, G., Anastasi, J., Doherty, D., Montag, A. G. Peabody, T. D. et al. (2003) Oncologic outcomes of primary lymphoma of bone in adults. Clin Orthop Relat Res, 415, pp. 90-97.
11. Clayton, F., Butler, J. J., Ayala, A. G., Ro, J. Y. and Zornoza, J. (1987) Non-Hodgkin's lymphoma of bone. Cancer, 60, pp. 2494-2501.
12. Ramadan, K. M., Shenkier, T., Sehn, L. H., Gascoyne, R. D. and Connors, J. M. (2007) A clinicopathological retrospective study of 131 patients with primary bone lymphoma: A population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol, 18, pp. 129-135.
13. Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W. and Tubianna, M. (1971) Report of the committee on Hodkgin's disease staging classification. Cancer Res, 31, pp. 1860-1861.
14. Shipp, M. A., Harrington, D. P., Anderson, J. R., Armitage, J. O., Bonadonna, G. Brittinger, G. et al. (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med, 329, pp. 987-994.
15. Baar, J., Burkes, R. L., Bell, R., Blacksetin, M. D., Fernandes, B. and Langer, F. (1994) Primary non-Hodgkin's lymphoma of bone: A clinicopathologic study. Cancer, 73, pp. 1194-1199.
16. Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H. Bouabdallah, R. et al. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med, 346, pp. 235-242.
17. Fuegier, P., Van Hoof, A., Sebban, C., Solal-Celigny, P., Bouabdallah, R. Ferme, C. et al. (2005) Long-term results of the R-CHOP study in the treatment of elderly patient with diffuse large B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol, 23, pp. 4117-4126.
18. Sehn, L. H., Donaldson, J., Chhanabhai, M., Fitzgerald, C., Gill, K. Klasa, R. et al. (2005) Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol, 23, pp. 5027-5033.
19. Pfreundschuh, M., Trumper, L., Osterborg, A., Pettengell, R., Trneny, M. Imrie, K. et al. (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: A randomized controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol, 7, pp. 379-391.
20. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P., Chan, J KC Cleary, M. L. et al. (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood, 84, pp. 1361-1392.
21. McKelvey, E. M., Gottlieb, J. A., Wilson, H. E., Haut, A., Talley, R. W. Stephens, R. et al. (1976) Hydroxydaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer, 38, pp. 1484-1493.
22. Wilson, W. H., Bryant, G., Bates, S., Fojo, A., Wittes, R. E. Steinberg, S. M. et al. (1993) EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol, 11, pp. 1573-1582.
23. Shipp, M. A., Harrington, D. P., Klatt, M. M., Jochelson, M. S., Pinkus, G. S. Marshall, J. L. et al. (1986) Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med, 104, pp. 757-765.
24. Schein, P. S., DeVita, VT Jr, Hubbard, S., Chabner, B. A., Canellos, G. P. and Young, B. C. (1976) Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med, 85, pp. 417-427.
25. Mendenhall, N. P., Jones, J. J., Kramer, B. S., Hudson, T. M., Carter, R. L. Enneking, W. F. et al. (1987) The management of primary lymphoma of bone. Radiother Oncol, 9, pp. 137-145.
26. Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M. Mize, E. M. et al. (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med, 328, pp. 1002-1006.
27. Vose, J. M. (1998) Current approaches to the management of non-Hodgkin's lymphoma. Sem Oncol, 25, pp. 483-491.
28. Beal, K., Allen, L. and Yahalom, J. (2006) Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients. Cancer, 106, pp. 2652-2656.